NCT04620330 2024-01-12
RAMP202
Verastem, Inc.
Phase 2 Completed
Clinical Trials
5 trialsNCT01778803 2017-05-17
Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer
Verastem, Inc.
Phase 1 Completed
NCT01951690 2017-04-13
Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer
Verastem, Inc.
Phase 2 Completed
NCT01943292 2017-03-09
Phase I Dose Escalation Study of VS-6063 in Japanese Subjects With Non-Hematologic Malignancies
Verastem, Inc.
Phase 1 Completed
NCT00787033 2017-01-25
B0761001
Verastem, Inc.
Phase 1 Completed